secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kairos Pharma, LTD. (KAPA)
CIK:        0001962011
Form:       8-K
Filed at:   2026-05-18T12:31:29+00:00
Accession:  0001493152-26-024082
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kairos Pharma issues investor presentation for LD Micro Invitational; no material new data disclosed
--------------------------------------------------------------------------------

- Company issued investor presentation for presentation at LD Micro Invitational on May 18-19, 2026.
- CEO John Yu will present update on clinical program and partnering activities.
- No specific financial results, milestones, or clinical data endpoints provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1962011/000149315226024082/0001493152-26-024082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1962011/000149315226024082/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-024082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer